Bank Julius Baer & Co. Ltd, Zurich Provention Bio, Inc. Transaction History

Bank Julius Baer & Co. Ltd, Zurich

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$5.66 - $8.33 $7,386 - $10,870	-1,305 Closed	0 $0
Q2 2021 Jul 23, 2021	BUY	$6.71 - $11.04 $369 - $607	55 Added 4.4%	1,305 $11,000
Q1 2021 May 10, 2021	BUY	$10.12 - $19.45 $12,649 - $24,312	1,250 New	1,250 $13,000

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.